SUBIR GUHA: Open Payments
NPI 1104871029 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,818 in 84 payments from 27 companies in 2025. Trend: 2023 $1,590 · 2024 $1,445 · 2025 $1,818
Food & beverage: $1,776Education: $43
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $180 |
| Novo Nordisk Inc | 9 | $174 |
| Amgen Inc. | 11 | $162 |
| BETA BIONICS, INC. | 1 | $145 |
| Lilly USA, LLC | 10 | $135 |
| Mannkind Corporation | 5 | $134 |
| ABBVIE INC. | 5 | $100 |
| Xeris Pharmaceuticals, Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
Products named: Korlym, iLet Bionic Pancreas, MOUNJARO, AFREZZA, OTEZLA, GVOKE HYPOPEN, LEQVIO, CAPLYTA.
Industry payments across TN — which companies pay providers there.
